Form 8-K - Current report:
SEC Accession No. 0001384101-23-000007
Filing Date
2023-02-10
Accepted
2023-02-10 16:44:15
Documents
13
Period of Report
2023-02-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20230209.htm   iXBRL 8-K 44754
2 EX-3.1 BYLAWS ex31veracyte-amendedandres.htm EX-3.1 215894
  Complete submission text file 0001384101-23-000007.txt   448633

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20230209.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20230209_lab.xml EX-101.LAB 26255
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20230209_pre.xml EX-101.PRE 13693
7 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20230209_htm.xml XML 12454
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 23612827
SIC: 8071 Services-Medical Laboratories